JPH11322585A5 - - Google Patents

Info

Publication number
JPH11322585A5
JPH11322585A5 JP1999078680A JP7868099A JPH11322585A5 JP H11322585 A5 JPH11322585 A5 JP H11322585A5 JP 1999078680 A JP1999078680 A JP 1999078680A JP 7868099 A JP7868099 A JP 7868099A JP H11322585 A5 JPH11322585 A5 JP H11322585A5
Authority
JP
Japan
Prior art keywords
mixture
oxide
graft copolymer
copolymer
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999078680A
Other languages
English (en)
Japanese (ja)
Other versions
JP4813634B2 (ja
JPH11322585A (ja
Filing date
Publication date
Priority claimed from DE19812688A external-priority patent/DE19812688A1/de
Application filed filed Critical
Publication of JPH11322585A publication Critical patent/JPH11322585A/ja
Publication of JPH11322585A5 publication Critical patent/JPH11322585A5/ja
Application granted granted Critical
Publication of JP4813634B2 publication Critical patent/JP4813634B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP07868099A 1998-03-23 1999-03-23 固形投与形の製造法、該投与形及び結合剤としてのグラフトコポリマーの使用 Expired - Lifetime JP4813634B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812688.3 1998-03-23
DE19812688A DE19812688A1 (de) 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen

Publications (3)

Publication Number Publication Date
JPH11322585A JPH11322585A (ja) 1999-11-24
JPH11322585A5 true JPH11322585A5 (enExample) 2006-03-02
JP4813634B2 JP4813634B2 (ja) 2011-11-09

Family

ID=7861972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP07868099A Expired - Lifetime JP4813634B2 (ja) 1998-03-23 1999-03-23 固形投与形の製造法、該投与形及び結合剤としてのグラフトコポリマーの使用

Country Status (6)

Country Link
US (2) US7022344B1 (enExample)
EP (1) EP0950404B1 (enExample)
JP (1) JP4813634B2 (enExample)
AT (1) ATE269060T1 (enExample)
CA (1) CA2264287C (enExample)
DE (2) DE19812688A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814739A1 (de) * 1998-04-02 1999-10-07 Basf Ag Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
DE19847618A1 (de) * 1998-10-15 2000-04-20 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AU2004232370B2 (en) * 2003-04-21 2009-12-10 Euro-Celtique S.A. Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2548834C (en) * 2003-12-09 2009-08-11 Euro-Celtique S.A. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
JP4907514B2 (ja) * 2005-01-28 2012-03-28 株式会社リバース・プロテオミクス研究所 効率的にターゲット分子を探索する方法
WO2006125450A1 (en) * 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol
EP1920767A1 (en) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Melt-processed imatinib dosage form
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
RU2013118252A (ru) 2010-09-22 2014-10-27 МакНЕЙЛ-ППС, ИНК. Производство таблеток из порошковой смеси, обработанной излучением
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1043039A (en) * 1973-01-29 1978-11-21 Robert D. Lundberg Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
FR2433949A1 (fr) * 1978-08-25 1980-03-21 Commissariat Energie Atomique Substrat hydrophobe apte a liberer une substance chimique
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
KR970701739A (ko) 1994-03-04 1997-04-12 브라운 데이비드 피. 블록 공중합체와 그라프트 공중합체 및 이들과 연관된 방법(Block and graft copolymers and methods relating thereto)

Similar Documents

Publication Publication Date Title
JPH11322585A5 (enExample)
KR920003575B1 (ko) 고체 제약형태의 제조방법
DE50102650D1 (de) Hartkapseln, enthaltend Polymerisate von Vinylestern und Polyethern, deren Verwendung und Herstellung
CA2290528A1 (en) Method of making a water reducing additive for cement
DE59804928D1 (de) Verfahren zur herstellung von festen dosierungsformen
CA2377463A1 (en) Process for preparing comb-branched polymers
MXPA02010437A (es) Articulos de dosificacion solida comprimidos directamente.
CA2409828A1 (en) Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
BR9912353A (pt) Agente de revestimento e aglutinante para formas de medicamento orais e dérmicas
RU2013134339A (ru) Твердые составы с замедленным действием на основе твердой дисперсии
ATE222746T1 (de) Haarkosmetische formulierungen
ATE469961T1 (de) Film mit reinigungsmittel
CA2264287A1 (en) A process for producing solid dosage forms
CA2085917A1 (en) A process for preparing thermoplastic resin composition with excellent hcfc resistance
JPS6221804B2 (enExample)
US5629012A (en) Process for producing suppositories by compression and suppositories obtained by the process
JPS55165931A (en) Novel thermoplastic polymer composition
JPS5573740A (en) Improved composition
JPS57195135A (en) Heat-sealable resin composition
GB1262802A (en) Homogenous compositions of polyamides and polyolefins
JPS57203006A (en) Resin composition for denture base
JPS5363492A (en) Preparation of modified polyolefin
JPS61238844A (ja) 架橋非晶質共重合体ラテツクス組成物
WO2004098562A3 (en) Controlled release solid dosage nifedipine formulations
Gurruchaga et al. Synthesis of graft copolymers of hydrophobic and hydrophilic methacrylates onto amylopectin